Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Stephens & Co. Reiterates Overweight on Wendy’s, Maintains $27 Price Target

Stephens & Co. Reiterates Overweight on Wendy’s, Maintains $27 Price Target

Stephens & Co. analyst Joshua Long reiterates Wendy's (NASDAQ:WEN) with a Overweight and maintains $27 price target.

byBenzinga Newsdesk

March 1, 2023

1 minute read

Stephens & Co. analyst Joshua Long reiterates Wendy’s (NASDAQ:WEN) with a Overweight and maintains $27 price target.

Zions Bancorp’s Q2 2023 Earnings Exceed Expectations: Analysts Increase Price Targets

By Lekha Gupta

July 20, 12:50 PM

Many analysts raised the price target of Zions Bancorp NA (NASDAQ: ZION) following

ZION

Why Nikola Stock Is Tumbling Monday

By Adam Eckert

August 21, 9:02 AM

Nikola Corp (NASDAQ: NKLA) shares are trading lower Monday after the company announced an areement to sell up to $325 million in aggregate principle amount of senior convertible notes.

NKLA

FDA Approves World’s First Mosquito-Borne Chikungunya Vaccine

By Vandana Singh

November 10, 9:37 AM

The FDA approved Valneva SE's (NASDAQ: VALN) Chikungunya single-dose vaccine in individuals

VALN

MrBeast Signs Deal With NBA Team For Feastables Jersey Sponsorship: Here Are The Details, Why It’s Important

By Chris Katje

October 2, 7:45 PM

The most followed individual on YouTube, MrBeast, has built a loyal following of fans and a brand that could be worth billions of dollars.

GOOG

Stephens & Co. Reiterates Overweight on Wendy’s, Maintains $27 Price Target

Related Posts

Zions Bancorp’s Q2 2023 Earnings Exceed Expectations: Analysts Increase Price Targets

Why Nikola Stock Is Tumbling Monday

FDA Approves World’s First Mosquito-Borne Chikungunya Vaccine

MrBeast Signs Deal With NBA Team For Feastables Jersey Sponsorship: Here Are The Details, Why It’s Important